SA-16002
N/A
Report date: 2022/12/03 23:08:06
NME
Base Information
Drug NameSA-16002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSama Pharma
China Registration ClassN/A
Develop Information
Active CompaniesSama Pharma
Inactive CompaniesSama Pharmaceutical Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A